EIF2S2 | Eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
ELF3 | E74-like factor 3 (ets domain transcription factor, epithelial-specific ) | Cancer-related genes Transcription factors
| | | | | Mixed |
EP300 | E1A binding protein p300 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERBB3 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
EZH1 | Enhancer of zeste homolog 1 (Drosophila) | Cancer-related genes Enzymes
| | | | | Expressed in all |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
EZR | Ezrin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
FBXW7 | F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase | Cancer-related genes Predicted secreted proteins
| | | | | Expressed in all |
FGFBP1 | Fibroblast growth factor binding protein 1 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
FGFR2 | Fibroblast growth factor receptor 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
FGFR3 | Fibroblast growth factor receptor 3 | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
FLG | Filaggrin | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
FOXA1 | Forkhead box A1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
FOXQ1 | Forkhead box Q1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GUSB | Glucuronidase, beta | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
HIST1H1E | Histone cluster 1, H1e | Cancer-related genes
| | | | | Tissue enriched |
HIST1H3B | Histone cluster 1, H3b | Cancer-related genes
| | | | | Tissue enriched |
HSP90AB1 | Heat shock protein 90kDa alpha (cytosolic), class B member 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
IDH1 | Isocitrate dehydrogenase 1 (NADP+), soluble | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
IDH2 | Isocitrate dehydrogenase 2 (NADP+), mitochondrial | Cancer-related genes Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
IL7R | Interleukin 7 receptor | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ING1 | Inhibitor of growth family, member 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
INPPL1 | Inositol polyphosphate phosphatase-like 1 | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
INTS12 | Integrator complex subunit 12 | Cancer-related genes
| | | | | Expressed in all |
IPO7 | Importin 7 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
KEAP1 | Kelch-like ECH-associated protein 1 | Cancer-related genes FDA approved drug targets
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KLHL8 | Kelch-like family member 8 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Transcription factors
| | | | | Expressed in all |
MAP2K1 | Mitogen-activated protein kinase kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets RAS pathway related proteins
| | | | | Expressed in all |
MAP3K1 | Mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MBD1 | Methyl-CpG binding domain protein 1 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MED12 | Mediator complex subunit 12 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MET | Met proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
MGA | MGA, MAX dimerization protein | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MUC17 | Mucin 17, cell surface associated | Cancer-related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MYB | V-myb avian myeloblastosis viral oncogene homolog | Cancer-related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
NCOR1 | Nuclear receptor corepressor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
NFE2L2 | Nuclear factor, erythroid 2-like 2 | Cancer-related genes Transcription factors
| | | | | Expressed in all |
NOTCH1 | Notch 1 | Cancer-related genes Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
NPM1 | Nucleophosmin (nucleolar phosphoprotein B23, numatrin) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
NSD1 | Nuclear receptor binding SET domain protein 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ODAM | Odontogenic, ameloblast asssociated | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |